Advertisement
Screener

Definium Therapeutics, Inc. (DFTX) Price / Book

2.8 / 5 stars · 68/120 Roast Me

Definium Therapeutics, Inc. Price/Book Ratio

The price-to-book (P/B) ratio compares what the stock market says a company is worth with what the company's own books say it is worth. It is market capitalization divided by shareholder equity, the book value left after subtracting liabilities from assets, and the table shows both amounts. A ratio of 1.0 means market value equals book value; a higher ratio means investors value the company above its net assets, often for brands, software or expected growth the books do not record. A negative ratio means equity is negative. Each point uses the filed share count and the last closing price on or before the equity's reporting date, never today's price.

  • Definium Therapeutics, Inc. price/book ratio for the quarter ending 2026-06-30 was 6.88, a 159.28% increase year-over-year.
  • Definium Therapeutics, Inc. price/book ratio for the quarter ending 2026-03-31 was 7.05, a 255.50% increase year-over-year.
  • Definium Therapeutics, Inc. price/book ratio for the quarter ending 2025-12-31 was 3.98, a 83.84% increase year-over-year.
  • Definium Therapeutics, Inc. price/book ratio for the quarter ending 2025-09-30 was 6.93, a 291.44% increase year-over-year.
  • Definium Therapeutics, Inc. price/book ratio for fiscal 2026 was 6.88.
  • Definium Therapeutics, Inc. price/book ratio for fiscal 2025 was 3.98, a 83.84% increase from fiscal 2024.
  • Definium Therapeutics, Inc. price/book ratio for fiscal 2024 was 2.16, a 12.44% increase from fiscal 2023.
  • Definium Therapeutics, Inc. price/book ratio for fiscal 2023 was 1.93, a 247.75% increase from fiscal 2022.
Available history
2021-12-31 to 2026-06-30
Data captured

Historical Price/Book Ratio

DatePrice/Book RatioMarket capitalizationShareholder equity
2026-06-306.88$6.32B$918.68M
2026-03-317.05$1.97B$278.85M
2025-12-313.98$1.32B$332.33M
2025-09-306.93$905.17M$130.6M
2025-06-302.65$491.96M$185.4M
2025-03-311.98$441.74M$222.81M
2024-12-312.16$522.7M$241.45M
2024-09-301.77$464.25M$262.19M
2024-06-302.57$519.66M$202.05M
2024-03-313.41$668.94M$196.06M
2023-12-311.93$150.43M$78.13M
2023-09-301.31$125.5M$95.98M
2023-06-301.31$138.54M$105.97M
2023-03-310.93$121.38M$130.34M
2022-12-310.55$83.55M$150.92M
2022-09-300.86$131.39M$153.59M
2022-06-3032.9$4.1B$124.5M
2022-03-3151.35$7.02B$136.81M
2021-12-313.84$582.22M$151.66M

Annual Price/Book Ratio

DatePrice/Book RatioMarket capitalizationShareholder equity
2026-06-306.88$6.32B$918.68M
2025-12-313.98$1.32B$332.33M
2024-12-312.16$522.7M$241.45M
2023-12-311.93$150.43M$78.13M
2022-12-310.55$83.55M$150.92M
2021-12-313.84$582.22M$151.66M

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cronos Group Inc. (CRON)$1.223B
Tilray Brands, Inc. (TLRY)United States$0.554B-5.97
Canopy Growth Corp (CGC)$0.395B
USANA HEALTH SCIENCES INC (USNA)United States$0.264B-17.90
Niagen Bioscience, Inc. (NAGE)United States$0.238B15.72
FITLIFE BRANDS, INC. (FTLF)United States$0.087B16.59
MANNATECH INC (MTEX)United States$0.014B
NATURAL ALTERNATIVES INTERNATIONAL INC (NAII)United States$0.011B-1.16
Synergy CHC Corp. (SNYR)United States$0.001B
Functional Brands Inc. (MEHA)United States$0.001B